WHO ICTRP trial

The mechanism of Shenlingbaizhu Powder for peptic ulcer treatment Efficacy and…

ChiCTR2300070322 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2300070322
Public title The mechanism of Shenlingbaizhu Powder for peptic ulcer treatment Efficacy and safety evaluation – retrospective cohort studies
Scientific title The mechanism of Shenlingbaizhu Powder for peptic ulcer treatment Efficacy and safety evaluation – retrospective cohort studies
Primary sponsor Nanchang Hongdu Hospital of Traditional Chinese Medicine
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Treatment study
Phase Retrospective study
Countries China
Conditions Peptic ulcer
Interventions Exposure group (Shenlingbaizhu Powder;Shenlingbaizhu Powder + other therapies):None;Non-exposure group( other therapies):None
Registration date Apr 10, 2023
Target size Exposure group (Shenlingbaizhu Powder;Shenlingbaizhu Powder + other…
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations